Abpro Holdings (ABPO) Research & Development (2024 - 2026)
Abpro Holdings' Research & Development came in at $9,000 for Q2 2026, down 97.1% from $313,000 a year earlier and down 30.8% from the prior quarter.
Powered by 
Analysis
Abpro Holdings (ABPO) Research & Development (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Abpro Holdings reported Research & Development of $373,000, down 79.2% year-over-year; for FY2025, it came in at $989,000, down 66.8% from FY2024.
- Going back by year, Research & Development was $2.98 million in FY2024 (-30.1%) and $4.27 million in FY2023.
- The Q2 2026 figure represents the lowest quarterly Research & Development in data going back to Q1 2024.
- Year-over-year, Research & Development has declined for six consecutive quarters, with an average decline of 77.3% over the last six quarters.
- Business Quant data shows ABPO's Research & Development at $13,000 (Q1 2026), $108,000 (Q4 2025) and $243,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.62 Bn | 1,105.21 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 617.59 Bn | 536.12 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.69 Bn | 474.80 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 368.29 Bn | 322.67 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.79 Bn | 261.78 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 260.82 Bn | 234.50 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.14 Bn | 165.33 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.69 Bn | 116.33 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Abpro Holdings | 2.36 Mn | -7.68 Mn | - | 9,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 313,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Sep 30, 2024 | 642,000.00 |
| Jun 30, 2024 | 827,000.00 |
| Mar 31, 2024 | 1.00 Mn |
API Access
Abpro Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ABPO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ABPO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ABPO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();